Global Closure Devices Market Size By Type (Percutaneous Closure Devices, Others), By Application (Hospital, Medical Center), By Region, And Segment Forecasts, 2023 to 2032

The Global Closure Devices Market was valued at USD 2.3 billion in 2023 and is projected to reach USD 4.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 7.4% during the forecast period from 2023 to 2031. The increasing incidence of cardiovascular diseases, rising demand for minimally invasive surgical procedures, and the growing number of catheterization and interventional radiology procedures are key factors driving market growth. Closure devices play a crucial role in ensuring hemostasis after arterial access, particularly in cardiovascular procedures, and are gaining widespread adoption for their ability to reduce complications and recovery time.

Drivers:

1. Growing Prevalence of Cardiovascular Disorders

The global rise in cardiovascular diseases, such as coronary artery disease and peripheral arterial disease, has increased the number of diagnostic and therapeutic catheter-based procedures, driving demand for vascular closure devices to ensure efficient wound closure post-intervention.

2. Advancements in Closure Device Technologies

Technological innovations, such as bioabsorbable plugs, suture-mediated closure systems, and device miniaturization, are enhancing safety and efficiency, improving patient outcomes, and boosting adoption rates among healthcare providers.

3. Increasing Preference for Minimally Invasive Procedures

Minimally invasive surgeries reduce hospital stay, healing time, and complications, and closure devices are integral in such procedures for effective hemostasis, supporting their growing demand.

Restraints:

1. High Cost of Advanced Closure Devices

The high upfront cost of technologically advanced closure devices can limit adoption, particularly in cost-sensitive markets and small healthcare facilities.

2. Device-Related Complications

Despite their benefits, closure devices can occasionally lead to complications such as hematoma, infection, or vascular injury, which may hinder market expansion if not mitigated.

Opportunity:

1. Expanding Healthcare Infrastructure in Emerging Markets

Countries in Asia-Pacific and Latin America are seeing improved healthcare investments and rising awareness, creating lucrative opportunities for closure device manufacturers to penetrate untapped markets.

2. Rise in Outpatient and Ambulatory Surgical Centers (ASCs)

The shift toward outpatient care and increased procedural volumes in ASCs drive demand for quick and reliable vascular closure solutions to enable same-day patient discharge.

Market by System Type Insights:

Based on system type, Suture-Based Closure Devices dominated the market in 2023 due to their widespread usage in large-bore procedures and proven efficacy. However, Plug-Based Closure Devices are expected to experience the fastest growth rate owing to their ease of use and reduced complication rates.

Market by End-use Insights:

In terms of end use, Hospitals held the largest market share in 2023, supported by a high volume of interventional procedures and access to trained medical professionals. Ambulatory Surgical Centers (ASCs) are expected to witness significant growth due to their cost-effectiveness and increasing adoption of same-day procedures.

Market by Regional Insights:

North America led the global closure devices market in 2023, driven by high procedural volumes, favorable reimbursement policies, and the presence of major market players. Meanwhile, Asia-Pacific is projected to grow at the highest CAGR due to a growing elderly population, increased healthcare access, and rising awareness about minimally invasive treatments.

Competitive Scenario:

Prominent players in the Global Closure Devices Market include Abbott Laboratories, Terumo Corporation, Cardinal Health, Boston Scientific Corporation, Medtronic plc, Teleflex Incorporated, and Morris Innovative. These companies are investing in product innovation, clinical trials, and geographical expansion to strengthen their market presence.

Recent Developments:

In 2023, Abbott launched its next-generation Perclose ProStyle™, improving ease of use and patient outcomes in large-bore arterial access procedures.

In 2024, Terumo received regulatory approval in Europe for its advanced plug-based closure system with biodegradable materials.

In 2025, Boston Scientific expanded its vascular closure device portfolio through the acquisition of a niche closure device developer specializing in next-gen plug-suture hybrid technologies.

Scope of Work – Global Closure Devices Market

Key Market Developments:

2023: Abbott introduced a fully automated suture-mediated closure device with reduced deployment time and improved accuracy.

2024: Terumo launched its new collagen-based plug closure system targeting high-volume cardiovascular centers.

2025: Teleflex announced strategic partnerships with hospital networks in India and Brazil to expand its closure device distribution channels.

FAQs:

1) What is the current market size of the Global Closure Devices Market?

The market was valued at USD 2.3 billion in 2023.

2) What is the major growth driver of the Global Closure Devices Market?

The key driver is the rising number of cardiovascular procedures and demand for minimally invasive hemostasis solutions.

3) Which is the largest region during the forecast period in the Global Closure Devices Market?

North America holds the largest share due to high healthcare spending and procedural volumes.

4) Which segment accounted for the largest market share in Global Closure Devices Market?

Suture-based closure devices dominated the market by system type in 2023.

5) Who are the key market players in the Global Closure Devices Market?

Key players include Abbott Laboratories, Terumo Corporation, Boston Scientific, Cardinal Health, Medtronic, and Teleflex.